Cost-effectiveness of raloxifene for the prevention of osteoporotic fractures in Australia

被引：0
|
作者：
Davey, PJ
Lees, M
Graham-Clarke, P
机构：
[1] Med Technol Assessment Grp, Chatswood, NSW, Australia
[2] Eli Lilly Australia Pty Ltd, W Ryde, NSW, Australia
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)63913-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of raloxifene to prevent osteoporotic fractures among postmenopausal women in Australia
    Lees, M
    Graham-Clarke, P
    Davey, P
    Thiebaud, D
    Grainger, D
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S28 - S28
  • [2] The cost-effectiveness of raloxifene compared with no drug therapy for the prevention of osteoporotic fractures when HRT is inappropriate: The case of Australia
    Davey, P
    Lees, M
    Graham-Clarke, P
    VALUE IN HEALTH, 2002, 5 (06) : 455 - 456
  • [3] Cost-effectiveness of alendronate in the prevention of osteoporotic fractures in Danish women
    Christensen, PM
    Brixen, K
    Gyrd-Hansen, D
    Kristiansen, IS
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (05) : 387 - 396
  • [4] Cost-effectiveness of teriparatide (Forteo) in the prevention of osteoporotic fractures among men and postmenopausal women in Australia
    Graham-Clarke, PL
    Lees, M
    Wolthers, T
    Thiebaud, D
    Price, N
    VALUE IN HEALTH, 2004, 7 (03) : 297 - 297
  • [5] Cost-effectiveness analysis of biphosphonates and raloxifene for treatment of osteoporosis and prevention of fractures
    Lau, TC
    Lim, BP
    Li, SC
    VALUE IN HEALTH, 2005, 8 (03) : 408 - 408
  • [6] Raloxifene for prevention of osteoporotic fractures
    Diehr, S
    Mijal, S
    Nashelsky, J
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (01) : 132 - 134
  • [7] COST-EFFECTIVENESS OF PRIMARY PREVENTION FOR OSTEOPOROTIC HIP FRACTURES IN ELDERLY WOMEN
    Comas, M.
    Posso, M.
    Louro, J.
    Espallargues, M.
    Tebe, C.
    Domingo, L.
    Castells, X.
    VALUE IN HEALTH, 2018, 21 : S295 - S295
  • [8] Cost-effectiveness of teriparatide in the prevention of osteoporotic fractures in Australian men and women
    Lees, M
    Graham-Clarke, P
    Davey, P
    Thiebaud, D
    Price, N
    Grainger, D
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S12 - S13
  • [9] COST-EFFECTIVENESS ANALYSIS OF ALENDRONATE THERAPY FOR SECONDARY PREVENTION OF OSTEOPOROTIC FRACTURES
    Moriwaki, K.
    Komaba, H.
    Noto, S.
    Yanagisawa, S.
    Takiguchi, T.
    Toujo, T.
    Inoue, H.
    Fukagawa, M.
    Takahashi, H. E.
    VALUE IN HEALTH, 2013, 16 (07) : A571 - A571
  • [10] THE COST-EFFECTIVENESS OF DENOSUMAB FOR THE PREVENTION OF OSTEOPOROTIC FRACTURES IN THE SETTING OF THE UNITED STATES
    Jiang, Y.
    Hay, J.
    VALUE IN HEALTH, 2012, 15 (04) : A38 - A38
12345